In Conversation

Puerto Rico Pharma Report January 2020
Latest Reports
Puerto Rico Pharma Report January 2020
- 2020
Puerto Rico has a stronger healthcare manufacturing footprint than any other US jurisdiction or State, with 50 pharma and 30 medical device sites dotted throughout the island. This footprint represents around 30 percent of Puerto Rico’s GDP and two of its major exports. Several multinational firms are doubling down on their commitment to manufacturing on Puerto Rico and an increasing number of small and medium-sized companies from Europe, Asia and Latin America are choosing to situate manufacturing sites there.   This report looks at the rationale behind these commitments, how Puerto Rico is innovating within pharmaceutical manufacturing, and the…
Puerto Rico Pharma Report
Latest Reports
Puerto Rico Pharma Report
- 2016
The report offers companies, investors, policymakers, and stakeholders with an interest in healthcare, pharmaceuticals, or life sciences insights into the fifth largest territory in the world for pharma manufacturing, a territory with significantly improved capabilities in R&D, medical device and diagnostics manufacturing, and more universities per square mile than anywhere else on the planet. It features interviews with senior executives from the major companies in Puerto Rico and leaders of the country’s most important institutions, updated facts and figures on Puerto Rico’s healthcare and pharma sectors, and an exclusive in-depth cover story, ‘Made in Puerto Rico’.
We use cookies to ensure that we give you the best experience on our site. For more info click here